| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/03/2015 | US8946209 Compositions and methods for treating and preventing urolithiasis and conditions associated therewith |
| 02/03/2015 | US8946208 Non-aqueous pharmaceutical composition |
| 02/03/2015 | US8946205 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
| 02/03/2015 | US8946200 Pharmaceutically active nanosuspensions |
| 02/03/2015 | US8946178 Compositions and methods for treatment of pouchitis |
| 02/03/2015 | US8946170 Sustained release siRNA for ocular drug delivery |
| 02/03/2015 | US8946167 Pharmaceutical compositions containing plasma protein |
| 02/03/2015 | US8946162 Treatment of tumors |
| 02/03/2015 | US8946161 Method of treatment using stable liquid formulation of G-CSF |
| 02/03/2015 | US8946156 Albumin Fusion Proteins |
| 02/03/2015 | US8946153 Fast dissolving pharmaceutical composition |
| 02/03/2015 | US8945927 Polymers for delivering molecules of interest |
| 02/03/2015 | US8945660 Edible foam product for the treatment or prevention of obesity |
| 02/03/2015 | US8945640 Genipin-rich material and its use |
| 02/03/2015 | US8945629 Nanoparticles for cytoplasmic drug delivery to cancer cells |
| 02/03/2015 | US8945628 Magnetic nanoparticles |
| 02/03/2015 | US8945627 Micelles for the solubilization of gossypol |
| 02/03/2015 | US8945626 Preparation of pharmaceutical compositions |
| 02/03/2015 | US8945625 Regulated delivery systems for inner ear drug application and uses thereof |
| 02/03/2015 | US8945624 Photoinitiated tissue filler |
| 02/03/2015 | US8945623 Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use |
| 02/03/2015 | US8945622 Sustained release composition of therapeutic agent |
| 02/03/2015 | US8945621 Method for treating a patient at risk for developing an NSAID-associated ulcer |
| 02/03/2015 | US8945620 Solid pharmaceutical compositions containing pregabalin |
| 02/03/2015 | US8945619 Shell-and-core dosage form approaching zero-order drug release |
| 02/03/2015 | US8945618 Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
| 02/03/2015 | US8945617 Extrudate and methods of using said extrudate |
| 02/03/2015 | US8945616 Controlled release budesonide minitablets |
| 02/03/2015 | US8945615 Controlled release budesonide minitablets |
| 02/03/2015 | US8945614 Oral drug delivery system |
| 02/03/2015 | US8945612 Capsules containing high doses of levodopa for pulmonary use |
| 02/03/2015 | US8945611 Artificial oxygen carriers and use thereof |
| 02/03/2015 | US8945609 Thermosetting neutralized chitosan composition forming a hydrogel, lyophilizate, and processes for producing the same |
| 02/03/2015 | US8945604 Ophthalmic device, and method of use thereof, for increasing ocular boundary lubrication |
| 02/03/2015 | US8945603 Sodium channel blocker delivery system with scleral lens |
| 02/03/2015 | US8945602 Porous photonic crystals for drug delivery to the eye |
| 02/03/2015 | US8945600 Methods of delivering pharmaceutical agents |
| 02/03/2015 | US8945598 Low temperature drying methods for forming drug-containing polymeric compositions |
| 02/03/2015 | US8945593 Orally ingested metabolic enhancer in oral thin film container |
| 02/03/2015 | US8945592 Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same |
| 02/03/2015 | US8945551 Biopolymer hybrid gel-depot delivery system |
| 02/03/2015 | US8945543 Stabilizer for protein preparation comprising meglumine and use thereof |
| 02/03/2015 | US8945535 Implant for the repair of a cartilage defect and method for manufacturing the implant |
| 02/03/2015 | US8945529 Biphasic lipid-vesicle compositions |
| 02/03/2015 | US8945517 Continuous silica production process and silica product prepared from same |
| 02/03/2015 | US8945516 Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| 02/03/2015 | US8945513 Star polymer nanoshells and methods of preparation thereof |
| 02/03/2015 | US8945511 Sensitive methods for detecting the presence of cancer associated with the over-expression of galectin-3 using biomarkers derived from galectin-3 |
| 02/03/2015 | US8945391 Organic polymers-separation membrane filter, and organic polymers-separation method |
| 02/03/2015 | US8945094 Apparatus and method for medication delivery using single input-single output (SISO) model predictive control |
| 02/03/2015 | US8945063 Hazardous agent injection system |
| 02/03/2015 | US8945061 Otic formulations, methods and devices |
| 02/03/2015 | US8945005 Controlled activation ingestible identifier |
| 02/03/2015 | CA2800113C Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 02/03/2015 | CA2781718C Process for the preparation of gadobenate dimeglumine complex in a solid form |
| 02/03/2015 | CA2755084C Omega-3 enriched fish oil-in-water parenteral nutrition emulsions |
| 02/03/2015 | CA2754101C Medical devices comprising gel for the treatment of vascular conditions |
| 02/03/2015 | CA2718277C Compositions and methods for transdermal oxybutynin therapy |
| 02/03/2015 | CA2695952C Micro-particles, blood-substitute and method for forming same |
| 02/03/2015 | CA2677322C Complementary personal lubricant compositions and delivery system |
| 02/03/2015 | CA2656823C Cyanocobalamin low viscosity aqueous formulations for intranasal delivery |
| 02/03/2015 | CA2645855C Modified release formulations containing drug-ion exchange resin complexes |
| 02/03/2015 | CA2522765C Dietary supplement and method for the treatment and prevention of digestive tract ulcers in equines and other animals |
| 01/29/2015 | WO2015013678A2 Stable fatty acid compositions |
| 01/29/2015 | WO2015013673A1 Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use |
| 01/29/2015 | WO2015013596A2 Method and device for manufacturing polymer particles containing a therapeutic material |
| 01/29/2015 | WO2015013566A1 Nanoemulsions of hydrophobic platinum derivative |
| 01/29/2015 | WO2015013451A2 Compositions and methods for upregulating hippocampal plasticity and hippocampus-dependent learning and memory |
| 01/29/2015 | WO2015013336A1 Formulation of metaxalone |
| 01/29/2015 | WO2015012987A1 Partial melt co-crystallization compositions |
| 01/29/2015 | WO2015012899A1 Pharmaceutical compositions for intraocular administration comprising an antibacterial agent and an antiinflammatory agent |
| 01/29/2015 | WO2015012780A1 Medicinal agent having a cerebroprotective effect |
| 01/29/2015 | WO2015012779A1 Medicinal agent having a cardioprotective effect |
| 01/29/2015 | WO2015012758A1 Apparatus and method for generating an aerosol |
| 01/29/2015 | WO2015012633A1 Complex formulation containing sustained release metformin and immediate release hmg-coa reductase inhibitor |
| 01/29/2015 | WO2015011977A1 Subcutaneous injection preparation for inducing bovine superovulation |
| 01/29/2015 | WO2015011730A1 Formulation comprising a hypolipidemic agent |
| 01/29/2015 | WO2015011653A1 pH RESPONSIVE ORAL POLYMERIC PHARMACEUTICAL DOSAGE FORM |
| 01/29/2015 | WO2015011633A1 Compositions and methods for delivering messenger rna |
| 01/29/2015 | WO2015011419A1 Multicompartmental lipid nanoparticles |
| 01/29/2015 | WO2015011271A1 Improved powderous formulations of organic acids or esters having an aromatic ring system |
| 01/29/2015 | WO2015011264A1 Improved powderous formulations of organic acid amides hav-ing an aromatic ring system |
| 01/29/2015 | WO2015011244A1 SALTS OF 2-AMINO-1-HYDROXYETHYL-8-HYDROXYQUINOLIN-2(1H)-ONE DERIVATIVES HAVING BOTH MUSCARINIC RECEPTOR ANTAGONIST AND β2 ADRENERGIC RECEPTOR AGONIST ACTIVITIES |
| 01/29/2015 | WO2015011188A1 Fibroin-based pharmaceutical spray compositions for the treatment of skin lesions |
| 01/29/2015 | WO2015011163A1 Antitubercular composition comprising rifampicin, isoniazid, ethambutol and pyrazinamide and its process of preparation. |
| 01/29/2015 | WO2015011162A1 Anti-tuberculosis stable pharmaceutical composition in a form of a dispersible tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation |
| 01/29/2015 | WO2015011161A1 Anti-tuberculosis stable pharmaceutical composition in a form of a coated tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation |
| 01/29/2015 | WO2015011113A1 Formulations containing amorphous dapagliflozin |
| 01/29/2015 | WO2015011104A1 Polysaccharide hydrogels for injection with tunable properties |
| 01/29/2015 | WO2015010927A1 Pharmaceutical composition for oral insulin administration comprising a tablet core and an anionic copolymer coating |
| 01/29/2015 | WO2015010293A1 Anticancer pharmaceutical composition, preparation method for same, and use thereof |
| 01/29/2015 | US20150031770 Pharmaceutical Formulations of HDAC Inhibitors |
| 01/29/2015 | US20150031761 Use of 5-aminolevulinic acid and derivatives in a solid form for photodynamic treatment and diagnosis |
| 01/29/2015 | US20150031753 Complexing agents for compositions containing inclusion complexes |
| 01/29/2015 | US20150031737 Stabilized controlled-release pharmaceutical composition comprising gliclazide |
| 01/29/2015 | US20150031732 Febuxostat solid dispersion |
| 01/29/2015 | US20150031724 Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
| 01/29/2015 | US20150031719 Topical Therapy for the Treatment of Migraines, Muscle Sprains, Muscle Spasms, Spasticity and Related Conditions |
| 01/29/2015 | US20150031712 Therapeutic Compositions Containing Dipyridamole and Treatment Packs Including Such Compositions and Methods for Producing Same |
| 01/29/2015 | US20150031707 Method for preparing nano particles |